Tanaz Hashemi
About the Seminar
Drug Discovery: How We Got Here and Where We Might Be Going
Over the past 35 years, drug discovery has gone from carbon-paper forms and no email service to the modern environment of machine learning and AI. This talk will give an overview of how the process has changed, and what parts of it have remained (stubbornly) the same – and why
About the Speaker
Derek Lowe received his PhD in 1988, and after a post-doc year began his career in the drug industry at Schering-Plough, working on central nervous system drugs. After eight years he moved to Bayer to do metabolic research, and ten years later moved to Vertex Pharmaceuticals as a chemical biologist and specialist in new technologies, where he also worked on antibacterial, antiviral, and oncology targets. Since 2017 he has been a Director in Chemical Biology at Novartis, working on new discovery techniques